Cardiology

Assessing heart disease risk is within arm's reach

Atherosclerosis, commonly known as hardening of the arteries, has long been seen as a strong indicator of coronary artery disease, as compared to the traditional risk factors of race, age, gender and metabolic profile. Unlike ...

Medical research

Team advances research on metabolic syndrome

Building on their recent research focusing on a peptide, pNaKtide, designed to block the oxidant amplifying function of the cellular sodium-potassium pump, researchers at Marshall University Joan C. Edwards School of Medicine ...

Cardiology

Endogenous peptide lowers cholesterol

Cells of the innate immune system that play an important role in development of atherosclerosis contain a protein that reduces levels of cholesterol in mice – and thus helps to inhibit or mitigate the disease.

Cardiology

AHA: secondhand tobacco smoke ups atherosclerosis risk

(HealthDay)—In asymptomatic never smokers, the extent of secondhand tobacco smoke (SHTS) exposure is associated with the presence and extent of atherosclerosis, according to a study published online Nov. 13 in JACC: Cardiovascular ...

Cardiology

Two-year results of the COLOR trial presented

Two-year results from COLOR, the first large-scale multicenter prospective study of its kind, found that PCI on coronary artery lipid-rich plaque (LRP) detected by near infrared spectroscopy (NIRS) was not associated with ...

Genetics

Activation of two genes linked to development of atherosclerosis

Researchers at Brigham and Women's Hospital have found two new potential drug targets for treating arterial diseases such as atherosclerosis. By using proteomics to screen a vast number of molecules, the researchers identified ...

page 5 from 21